Urotensin II: Molecular Mechanisms of Biological Activity

被引:19
作者
Svistunov, Andrey A. [1 ]
Tarasov, Vadim V. [1 ]
Shakhmardanova, Svetlana A. [1 ]
Sologova, Susanna S. [1 ]
Bagaturiya, Ekaterina T. [1 ]
Chubarev, Vladimir N. [1 ]
Galenko-Yaroshevsky, Pavel A. [2 ]
Fidel Avila-Rodriguez, Marco [3 ]
Barreto, George E. [4 ,5 ]
Aliev, Gjumrakch [6 ,7 ,8 ]
机构
[1] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 19991, Russia
[2] Kuban State Med Univ, Krasnodar 350063, Russia
[3] Univ Tolima, Fac Ciencias Salud, Dept Ciencias Clin, Ibague, Colombia
[4] Pontificia Univ Javeriama, Dept Nutr & Bioquim, Fac Ciencias, Bogota, DC, Colombia
[5] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile
[6] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur,Dr 330, San Antonio, TX 78229 USA
[7] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA
[8] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia
关键词
Urotensin II; regulatory peptides; molecular targets of Urotensin II in cardiovascular; nervous; hormonal systems; stress; kidney; sexual function; cancer; G-protein-coupled receptors; drug design; TYPE-2; DIABETES-MELLITUS; AORTIC ADVENTITIAL FIBROBLASTS; SMOOTH-MUSCLE-CELLS; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; CAROTID ATHEROSCLEROSIS; DEPENDENT VASODILATOR; CARDIAC FIBROSIS; PROGENITOR CELLS; CALCIUM-ENTRY;
D O I
10.2174/1389203718666170829162335
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin II (UT II) is an important factor of cellular homeostasis. This regulatory peptide is involved in the pathophysiology of many disorders. For example, it plays an important role in the pathogenesis of acute and chronic diseases, stressful and adaptive reactions of the body, in the development of cardiovascular pathologies, metabolic syndrome, inflammation, liver cirrhosis, renal failure, diabetic nephropathy, reproductive dysfunction, progression of psychosomatic, psychoendocrinal and psychiatric disorders. In this concern, the involvement of UT II in the pathophysiology of many processes determines the perspectives for the development of blockers of urotensin receptors for the treatment of the aforementioned diseases. It is important that even today this kind of perspective is feasible due to the synthesis of a series of GPR14 blockers. The objective of this review is to discuss current molecular mechanisms of biological activity, regulatory functions of UT II, its role in the pathogenesis of different nosologies, as well as analysis of the possible routes of exposure to GPR14 as potential therapeutic targets.
引用
收藏
页码:924 / 934
页数:11
相关论文
共 130 条
[1]   The Urotensin II Systemand Carotid Atherosclerosis: A Role in Vascular Calcification [J].
Albanese, Isabella ;
Daskalopoulou, Stella S. ;
Yu, Bin ;
You, Zhipeng ;
Genest, Jacques ;
Alsheikh-Ali, Alawi ;
Schwertani, Adel G. .
FRONTIERS IN PHARMACOLOGY, 2016, 7
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]  
Anari R, 2017, DIABETES METAB SYND, V11, P37, DOI 10.1016/j.dsx.2016.07.004
[4]   Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome? [J].
Babinska, Magdalena ;
Holecki, Michal ;
Prochaczek, Fryderyk ;
Owczarek, Aleksander ;
Kokocinska, Danuta ;
Chudek, Jerzy ;
Wiecek, Andrzej .
ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) :449-454
[5]   Urotensin-II immunoreactivity in children with chronic glomerulonephritis [J].
Balat, Ayse ;
Karakok, Metin ;
Yilmaz, Kutluhan ;
Kibar, Yasernin .
RENAL FAILURE, 2007, 29 (05) :573-578
[6]  
Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165
[7]  
Bershova T. V, 2009, Pediatriya (Moscow), V88, P147
[8]   RETRACTED: Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS (Retracted Article) [J].
Bianca, Roberta d'Emmanuele di Villa ;
Mitidieri, Emma ;
Fusco, Ferdinando ;
D'Aiuto, Elena ;
Grieco, Paolo ;
Novellino, Ettore ;
Imbimbo, Ciro ;
Mirone, Vincenzo ;
Cirino, Giuseppe ;
Sorrentino, Raffaella .
PLOS ONE, 2012, 7 (02)
[9]   Urotensin II: A Novel Target in Human Corpus Cavernosum [J].
Bianca, Roberta d'Emmanuele di Villa ;
Cirino, Giuseppe ;
Mitidieri, Emma ;
Coletta, Ciro ;
Grassia, Gianluca ;
Roviezzo, Fiorentina ;
Grieco, Paolo ;
Novellino, Ettore ;
Imbimbo, Ciro ;
Mirone, Vincenzo ;
Sorrentino, Raffaella .
JOURNAL OF SEXUAL MEDICINE, 2010, 7 (05) :1778-1786
[10]   Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries [J].
Bottrill, FE ;
Douglas, SA ;
Hiley, CR ;
White, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1865-1870